Lodestar Private Asset Management LLC Bristol Myers Squibb CO Transaction History

Lodestar Private Asset Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 25, 2024	BUY	$47.98 - $54.4 $19,383 - $21,977	404 Added 9.51%	4,654 $252 Million
Q4 2023 Jan 29, 2024	SELL	$48.48 - $57.85 $15,998 - $19,090	-330 Reduced 7.21%	4,250 $218 Million
Q3 2023 Oct 31, 2023	SELL	$57.89 - $64.73 $11,867 - $13,269	-205 Reduced 4.28%	4,580 $266 Million
Q2 2023 Jul 27, 2023	SELL	$63.71 - $70.74 $9,365 - $10,398	-147 Reduced 2.98%	4,785 $306 Million
Q1 2023 Apr 25, 2023	BUY	$65.71 - $74.53 $328 - $372	5 Added 0.1%	4,932 $342 Million

Q4 2022 Feb 02, 2023	BUY	$68.48 - $81.09 $337,400 - $399,530	4,927 New	4,927 $354 Million

2,469

1.49B

26M

20M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $104B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Lodestar Private Asset Management LLC, based on Form 13F filings with the SEC.

Stay updated on Lodestar Private Asset Management LLC with notifications on news.